GSK3B and Huntington disease: Indeed, inhibition of GSK3β (Fig. 4) or excess ERK (Fig. 7) rescued HD phenotypes and decreased axonal transport defects and HTT aggregation, in contrast to inhibition of ERK (Fig. 6) or excess GSK3β (Fig. S6).